Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2024 Earnings Call Transcript March 13, 2025
Cellectar Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.38.
Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode. Following the presentation, there will be a question-and-answer session. Please be advised that today’s conference call may be recorded. I would now like to hand the...
